KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio (2020 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Debt Ratio for 9 consecutive years, with 0.02 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 38.23% to 0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02 through Dec 2025, down 38.23% year-over-year, with the annual reading at 0.02 for FY2025, 38.23% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.02 at Supernus Pharmaceuticals, up from 0.01 in the prior quarter.
  • The five-year high for Debt Ratio was 0.25 in Q4 2021, with the low at 0.01 in Q3 2025.
  • Average Debt Ratio over 5 years is 0.04, with a median of 0.03 recorded in 2022.
  • The sharpest move saw Debt Ratio soared 1122.11% in 2021, then tumbled 95.06% in 2022.
  • Over 5 years, Debt Ratio stood at 0.25 in 2021, then tumbled by 95.06% to 0.01 in 2022, then skyrocketed by 228.52% to 0.04 in 2023, then dropped by 15.09% to 0.03 in 2024, then plummeted by 38.23% to 0.02 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.02, 0.01, and 0.02 for Q4 2025, Q3 2025, and Q1 2025 respectively.